secwatch.observer — SEC 8-K summary
======================================

Issuer:     ELITE PHARMACEUTICALS INC /NV/ (ELTP)
CIK:        0001053369
Form:       8-K
Filed at:   2025-04-30T23:59:59+00:00
Accession:  0001641172-25-007836
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elite launches generic Percocet (oxycodone/acetaminophen) tablets in 3 strengths
--------------------------------------------------------------------------------

- Launched generic oxycodone HCl/acetaminophen tablets in 5/325, 7.5/325, and 10/325 mg strengths.
- Product is indicated for moderate to moderately severe pain, marketed under Elite Laboratories label.
- IQVIA reported 2024 brand sales of ~$317 million for the reference product.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1053369/000164117225007836/0001641172-25-007836-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1053369/000164117225007836/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-007836

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer